AR
Acrux Limited
ARUXF · OTC
$0.00 +0.00% (+$0.00)
Market Cap $9.52M
P/E Ratio -
Div. Yield -
ROE 34.00%
Piotroski F-Score Weak
2/9Valuation
76 /100
Cheap P/S 2.05x
P/B 6.50x
P/FCF 9.36x
Growth
34 /100
Stable Rev. growth 18.06%
FCF growth 20.33%
Book val. growth 44.77%
Profitability
50 /100
Moderate Gross margin 90.57%
Net margin 13.01%
Op. margin 46.06%
Quality
9 /100
Poor ROIC 10.70%
ROE 34.00%
ROA 8.85%
Debt
28 /100
High Debt/Equity 1.72x
Current ratio 1.37x
Int. coverage -7.59x
Stability
24 /100
Unstable Beta 0.97x
Rev. volatility 201.66%
EPS volatility 405.48%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na ARUXF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
John Warmbrunn
Employees
43
Headquarters
West Melbourne
Nadcházející události
02 BŘE
Earnings
Upcoming earnings report